Corrigendum to "Corticotropin releasing factor-induced ERK phosphorylation in AtT20 cells occurs via a cAMP-dependent mechanism requiring EPAC2" [Neuropharmacology 58 (2010) 135-144] (DOI:10.1016/j.neuropharm.2009.06.022);Corticotropin releasing factor-induced ERK phosphorylation in AtT20 cells occurs via a cAMP-dependent mechanism requiring EPAC2

Neuropharmacology

Volumn 58, Issue 1, 2010, Pages 135-144

  Van Kolen, Kristof ^a   Verstraeten, Karin ^a   Royaux, Ines ^a   De Hoogt, Ronald ^a   Gutknecht, Eric ^a   Peeters, Pieter J ^a  

^a JANSSEN RESEARCH AND DEVELOPMENT   (Belgium)

Author keywords

AtT20; CRF; EPAC; ERK phosphorylation

Indexed keywords

ANTIPORTER; CALCIUM; CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR RECEPTOR 1; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP DEPENDENT PROTEIN KINASE INHIBITOR; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; ETHYLENE GLYCOL 1,2 BIS(2 AMINOPHENYL) ETHER N,N,N',N' TETRAACETIC ACID; EXCHANGE PROTEIN DIRECTLY ACTIVATED BY CYCLIC AMP; FORSKOLIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PERTUSSIS TOXIN; PROOPIOMELANOCORTIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; UROCORTIN I;

ANIMAL CELL; ARTICLE; CALCIUM MOBILIZATION; CELL STRAIN HEK293; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVITY; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

EID: 71549144417     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2009.11.009     Document Type: Erratum

References (39)

1. Bos J.L. Epac: a new cAMP target and new avenues in cAMP research. Nat. Rev. Mol. Cell Biol. 4 (2003) 733-738
2. Brar B.K., Chen A., Perrin M.H., and Vale W. Specificity and regulation of extracellularly regulated kinase1/2 phosphorylation through corticotropin-releasing factor (CRF) receptors 1 and 2beta by the CRF/urocortin family of peptides. Endocrinology 145 (2004) 1718-1729
3. Brar B.K., Jonassen A.K., Egorina E.M., Chen A., Negro A., Perrin M.H., Mjos O.D., Latchman D.S., Lee K.F., and Vale W. Urocortin-II and urocortin-III are cardioprotective against ischemia reperfusion injury: an essential endogenous cardioprotective role for corticotropin releasing factor receptor type 2 in the murine heart. Endocrinology 145 (2004) 24-35
4. Chen C., Koh A.J., Datta N.S., Zhang J., Keller E.T., Xiao G., Franceschi R.T., D'Silva N.J., and McCauley L.K. Impact of the mitogen-activated protein kinase pathway on parathyroid hormone-related protein actions in osteoblasts. J. Biol. Chem. 279 (2004) 29121-29129
5. Cibelli G., Corsi P., Diana G., Vitiello F., and Thiel G. Corticotropin-releasing factor triggers neurite outgrowth of a catecholaminergic immortalized neuron via cAMP and MAP kinase signalling pathways. Eur. J. Neurosci. 13 (2001) 1339-1348
6. Daaka Y., Luttrell L.M., and Lefkowitz R.J. Switching of the coupling of the [beta]2-adrenergic receptor to different G proteins by protein kinase A. Nature 390 (1997) 88-91
7. Dautzenberg F.M., Gutknecht E., Van der Linden I., Olivares-Reyes J.A., Durrenberger F., and Hauger R.L. Cell-type specific calcium signaling by corticotropin-releasing factor type 1 (CRF1) and 2a (CRF2(a)) receptors: phospholipase C-mediated responses in human embryonic kidney 293 but not SK-N-MC neuroblastoma cells. Biochem. Pharmacol. 68 (2004) 1833-1844
8. Dautzenberg F.M., and Hauger R.L. The CRF peptide family and their receptors: yet more partners discovered. Trends Pharmacol. Sci. 23 (2002) 71-77
9. Davies S.P., Reddy H., Caivano M., and Cohen P. Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem. J. 351 (2000) 95-105
10. de Rooij J., Zwartkruis F.J.T., Verheijen M.H.G., Cool R.H., Nijman S.M.B., Wittinghofer A., and Bos J.L. Epac is a Rap1 guanine-nucleotide-exchange factor directly activated by cyclic AMP. Nature 396 (1998) 474-477
11. Dodge-Kafka K.L., and Kapiloff M.S. The mAKAP signaling complex: integration of cAMP, calcium, and MAP kinase signaling pathways. Eur. J. Cell Biol. 85 (2006) 593-602
12. Fang Y., and Olah M.E. Cyclic AMP-dependent, protein kinase A-independent activation of extracellular signal-regulated kinase 1/2 following adenosine receptor stimulation in human umbilical vein endothelial cells: role of exchange protein activated by cAMP 1 (Epac1). J. Pharmacol. Exp. Ther. 322 (2007) 1189-1200
13. Friedman J., Babu B., and Clark R.B. beta 2-Adrenergic receptor lacking the cyclic AMP-dependent protein kinase consensus sites fully activates extracellular signal-regulated kinase 1/2 in human embryonic kidney 293 cells: lack of evidence for Gs/Gi switching. Mol. Pharmacol. 62 (2002) 1094-1102
14. Gelinas J.N., Banko J.L., Peters M.M., Klann E., Weeber E.J., and Nguyen P.V. Activation of exchange protein activated by cyclic-AMP enhances long-lasting synaptic potentiation in the hippocampus. Learn. Memory 15 (2008) 403-411
15. Gerdin M.J., and Eiden L.E. Regulation of PC12 cell differentiation by cAMP signaling to ERK independent of PKA: do all the connections add up?. Sci. Signal. 2007 (2007) e15
16. Gutknecht E., Van der Linden I., Van Kolen K., Verhoeven K.F., Vauquelin G., and Dautzenberg F.M. Molecular mechanisms of corticotropin releasing factor receptor-induced calcium signaling. Mol. Pharmacol. 75 (2008) 648-657
17. Jones S.V. M4 muscarinic receptor subtype activates an inwardly rectifying potassium conductance in AtT20 cells. Neurosci. Lett. 147 (1992) 125-130
18. Kageyama K., Hanada K., Moriyama T., Imaizumi T., Satoh K., and Suda T. Differential regulation of CREB and ERK phosphorylation through corticotropin-releasing factor receptors type 1 and 2 in AtT-20 and A7r5 cells. Mol. Cell. Endocrinol. 263 (2007) 90-102
19. Kawasaki H., Springett G.M., Mochizuki N., Toki S., Nakaya M., Matsuda M., Housman D.E., and Graybiel A.M. A family of cAMP-binding proteins that directly activate Rap1. Science 282 (1998) 2275-2279
20. 2+-controlled activation of Ras and extracellular signal-regulated kinases by Gs-coupled receptors. J. Biol. Chem. 279 (2004) 46497-46508
21. Kooistra M.R.H., Corada M., Dejana E., and Bos J.L. Epac1 regulates integrity of endothelial cell junctions through VE-cadherin. FEBS Lett. 579 (2005) 4966-4972
22. Kovalovsky D., Refojo D., Liberman A.C., Hochbaum D., Pereda M.P., Coso O.A., Stalla G.K., Holsboer F., and Arzt E. Activation and induction of NUR77/NURR1 in corticotrophs by CRH/cAMP: involvement of calcium, protein kinase A, and MAPK pathways. Mol. Endocrinol. 16 (2002) 1638-1651
23. Laroche-Joubert N., Marsy S., Michelet S., Imbert-Teboul M., and Doucet A. Protein kinase A-independent activation of ERK and H, K-ATPase by cAMP in native kidney cells: role of Epac I. J. Biol. Chem. 277 (2002) 18598-18604
24. Lakatos A., Prinster S., Vicentic A., Hall R.A., and Kuhar M.J. Cocaine- and amphetamine-regulated transcript (CART) peptide activates the extracellular signal-regulated kinase (ERK) pathway in AtT20 cells via putative G-protein coupled receptors. Neurosci. Lett. 394 (2005) 198-202
25. Li H., Robinson P.J., Kawashima S., Funder J.W., and Liu J.P. Differential regulation of MAP kinase activity by corticotropin-releasing hormone in normal and neoplastic corticotropes. Int. J. Biochem. Cell Biol. 30 (1998) 1389-1401
26. Lopez-Ilasaca M. Signaling from G-protein-coupled receptors to mitogen-activated protein (MAP)-kinase cascades. Biochem. Pharmacol. 56 (1998) 269-277
27. Martin N.P., Whalen E.J., Zamah M.A., Pierce K.L., and Lefkowitz R.J. PKA-mediated phosphorylation of the [beta]1-adrenergic receptor promotes Gs/Gi switching. Cell. Signal. 16 (2004) 1397-1403
28. Mazzucchelli C., Vantaggiato C., Ciamei A., Fasano S., Pakhotin P., Krezel W., Welzl H., Wolfer D.P., Pages G., Valverde O., Marowsky A., Porrazzo A., Orban P.C., Maldonado R., Ehrengruber M.U., Cestari V., Lipp H.P., Chapman P.F., Pouyssegur J., and Brambilla R. Knockout of ERK1 MAP kinase enhances synaptic plasticity in the striatum and facilitates striatal-mediated learning and memory. Neuron 34 (2002) 807-820
29. Murray A.J. Pharmacological PKA inhibition: all may not be what it seems. Sci. Signal. 1 (2008) re4
30. Norum J.H., Methi T., Mattingly R.R., and Levy F.O. Endogenous expression and protein kinase A-dependent phosphorylation of the guanine nucleotide exchange factor Ras-GRF1 in human embryonic kidney 293 cells. FEBS J. 272 (2005) 2304-2316
31. Ouyang M., Zhang L., Zhu J.J., Schwede F., and Thomas S.A. Epac signaling is required for hippocampus-dependent memory retrieval. Proc. Natl. Acad. Sci. USA 105 (2008) 11993-11997
32. Peeters P.J., Gohlmann H.W., Van den Wyngaert I., Swagemakers S.M., Bijnens L., Kass S.U., and Steckler T. Transcriptional response to corticotropin-releasing factor in AtT-20 cells. Mol. Pharmacol. 66 (2004) 1083-1092
33. Punn A., Levine M.A., and Grammatopoulos D.K. Identification of signaling molecules mediating corticotropin-releasing hormone-R1{alpha}-mitogen-activated protein kinase (MAPK) interactions: the critical role of phosphatidylinositol 3-kinase in regulating ERK1/2 but not p38 MAPK activation. Mol. Endocrinol. 20 (2006) 3179-3195
34. Qiu W., Zhuang S., von Lintig F.C., Boss G.R., and Pilz R.B. Cell type-specific regulation of B-Raf kinase by cAMP and 14-3-3 proteins. J. Biol. Chem. 275 (2000) 31921-31929
35. Rehmann H., Das J., Knipscheer P., Wittinghofer A., and Bos J.L. Structure of the cyclic-AMP-responsive exchange factor Epac2 in its auto-inhibited state. Nature 439 (2006) 625-628
36. Rehmann H., Prakash B., Wolf E., Rueppel A., de Rooij J., Bos J.L., and Wittinghofer A. Structure and regulation of the cAMP-binding domains of Epac2. Nat. Struct. Mol. Biol. 10 (2003) 26-32
37. Roscioni S., Elzinga C., and Schmidt M. Epac: effectors and biological functions. Naunyn-Schmiedeberg's Arch. Pharmacol. 377 (2008) 345-357
38. Shah B.H., and Catt K.J. GPCR-mediated transactivation of RTKs in the CNS: mechanisms and consequences. Trends Neurosci. 27 (2004) 48-53
39. Stork P.J.S., and Schmitt J.M. Crosstalk between cAMP and MAP kinase signaling in the regulation of cell proliferation. Trends Cell Biol. 12 (2002) 258-266